Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.05783 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.97738 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.82493 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.47689 | 90 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.8735 | 93 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.87592 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.34916 | 95 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.76193 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.3835 | 91 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.78555 | 93 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.04842 | 94 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.66068 | 92 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.09295 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.81011 | 93 |